Response to Letter to the Editor on "Rivaroxaban Use for Thromboprophylaxis Is Associated With Early Periprosthetic Joint Infection"

J Arthroplasty. 2016 Sep;31(9):2079-80. doi: 10.1016/j.arth.2016.05.017. Epub 2016 May 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Infectious*
  • Arthroplasty, Replacement, Knee
  • Humans
  • Morpholines
  • Rivaroxaban*

Substances

  • Morpholines
  • Rivaroxaban